Vivo Capital, LLC Rezolute, Inc. Call Options Transaction History
Vivo Capital, LLC
- $368 Million
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding RZLT
# of Institutions
82Shares Held
39.7MCall Options Held
402KPut Options Held
19.4K-
Federated Hermes, Inc. Pittsburgh, PA11.3MShares$44 Million0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.38MShares$9.26 Million0.0% of portfolio
-
Marshall Wace, LLP London, X01.85MShares$7.2 Million0.01% of portfolio
-
Blackstone Inc New York, NY1.74MShares$6.8 Million0.02% of portfolio
-
Affinity Asset Advisors, LLC New York, NY1.7MShares$6.63 Million0.55% of portfolio
About Rezolute, Inc.
- Ticker RZLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,827,600
- Market Cap $151M
- Description
- Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultr...